| postarsphenamine jaundice | Liver toxicity, causing jaundice, in a patient who has received arsphenamine. (05 Mar 2000) |
|---|---|
| haematogenous jaundice | <haematology> Haemolytic jaundice is a type of jaundice, where the skin takes on a yellowish hue, which occurs when red blood cells have been destroyed (by haemolysis). (09 Oct 1997) |
| hepatocellular jaundice | Jaundice resulting from diffuse injury or inflammation or failure of function of the liver cells, usually referring to viral or toxic hepatitis. (05 Mar 2000) |
| hepatogenous jaundice | Jaundice resulting from disease of the liver, as distinguished from that due to blood changes. (05 Mar 2000) |
| Schmorl's jaundice | <paediatrics> Disorder due to jaundice in a newborn baby with high blood levels of the pigment bilirubin that is deposited in the brain resulting in damage. The level of bilirubin is monitored in newborns to determine whether treatment is needed to prevent kernicterus. With brain affected, it is also called bilirubin encephalopathy. (12 Dec 1998) |
| homologous serum jaundice | An obsolete term for viral hepatitis type B. (05 Mar 2000) |
| human serum jaundice | An obsolete name for hepatitis transmitted parenterally, usually by blood or blood products; usually due to hepatitis B. (05 Mar 2000) |
| spherocytic jaundice | Haemolytic jaundice associated with spherocytosis. (05 Mar 2000) |
| spirochetal jaundice | Jaundice caused by infection with Leptospira species, usually Leptospira icterohemorrhagica. (05 Mar 2000) |
| neonatal jaundice | Icterus which can be accentuated by many factors including excessive haemolysis, sepsis, neonatal hepatitis or congenital atresia of the biliary system. Synonym: physiologic icterus, jaundice of the newborn, neonatal jaundice, physiologic jaundice. (05 Mar 2000) |
| newborn jaundice | <paediatrics> A normal condition of elevated bilirubin in the bloodstream of a newborn. This occurs secondary to immaturity of liver cells (cannot effectively metabolise bilirubin) and the increased destruction of red blood cells (further releasing bilirubin into the bloodstream) that is normally seen in the newborn. The jaundice usually appears between the 2nd and 5th days of life and usually clears by 2 weeks. Other factors which can potentiate jaundice in the newborn include: sepsis, biliary atresia, Rhesus incompatibility, galactosaemia, cephalohaematoma, polycythaemia, G-6-P-D deficiency and congenital rubella, syphilis, toxoplasmosis or cytomegalovirus infection. (10 Jan 1998) |
| nonobstructive jaundice | <biochemistry, hepatology> Any jaundice in which the main biliary passages are not obstructed, e.g., haemolytic jaundice or jaundice due to hepatitis. (05 Mar 2000) |
| nuclear jaundice | <paediatrics> Disorder due to jaundice in a newborn baby with high blood levels of the pigment bilirubin that is deposited in the brain resulting in damage. The level of bilirubin is monitored in newborns to determine whether treatment is needed to prevent kernicterus. With brain affected, it is also called bilirubin encephalopathy. (12 Dec 1998) |
| infectious jaundice | Sometimes used in referring to viral hepatitis type A. See: Weil's disease (05 Mar 2000) |
| infective jaundice | Acute onset of malaise, fever, myalgia, nausea, anorexia, abdominal pain, and icterus caused by members of the genus Leptospira. (05 Mar 2000) |